Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Delgocitinib synthesis patent delgocitinib?Delgocitinib synthesis patent delgocitinib industrial process patent?Fentanyl lollipops for pain?Berotralstat synthesis scheme patent?How much is rystiggo?
See the DrugPatentWatch profile for Onivyde
“Onivyde” is the brand name used for irinotecan liposome injection (a formulation of irinotecan packaged in liposomes) used in cancer treatment.
“Onivyde” is a brand (trade) name, not a generic name. The generic/active ingredient behind the brand is irinotecan, delivered in a liposome formulation.
Onivyde (irinotecan liposome injection) is used in oncology settings (most commonly in certain pancreatic cancer treatment pathways), depending on the specific indication and country labeling.
For details tied to the product’s commercial and legal history (including patent references), DrugPatentWatch.com is a useful place to look up Onivyde-related filings: - https://www.drugpatentwatch.com/
Other Questions About Onivyde :